| Canakinumab therapy in patients with Familial Mediterranean Fever S Ugurlu, E Seyahi, G Hatemi, A Hacioglu, H Ozcan, FN Akkoc, ... Pediatric Rheumatology 13, 1-1, 2015 | 10 | 2015 |
| Immunogenicity of infliximab among patients with behcet syndrome: a controlled study SN Esatoglu, FN Akkoc-Mustafayev, Y Ozguler, F Ozbakır, OK Nohut, ... Frontiers in Immunology 11, 618973, 2020 | 6 | 2020 |
| Prognostic value of expression levels of miR‑148a, miR‑152 and HLA‑G in colon cancer LEOOFNAMUBIYSCBBOMA Ozgun Oncology Letters, 2022 | 5 | 2022 |
| The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification?(Turkish Oncology … M Hizal, B Bilgin, N Paksoy, MM Atcı, S Kahraman, S Kılıçkap, DC Güven, ... Journal of Cancer Research and Clinical Oncology 149 (8), 4141-4148, 2023 | 4 | 2023 |
| Clinical outcomes related to the use of bendamustine therapy for multiple myeloma patients Relapsed/Refractory to immunomodulatory drugs and proteasome inhibitors F Fırat Yalnız, N Akkoç, A Salihoğlu, MC Ar, Ş Öngören, AE Eşkazan, ... | 4 | 2017 |
| Gastric Ulcers Related to The Transarterial Radioembolization of Yittrium-90 in A Patient with Paraganglioma. K Atay, FN Akkoc, C Samanci, F Gülsen, N Kepil, I Hatemi Acta gastro-enterologica Belgica 80 (1), 85-86, 2017 | 3 | 2017 |
| FRI0477 Immunogenicity of infliximab among patients with behcet’s syndrome: a controlled study SN Esatoglu, FN Akkoc, Y Ozguler, F Ozbakir, OK Nohut, D Cevirgen, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 767-767, 2018 | 2 | 2018 |
| THU0402 Canakinumab Therapy in Patients With Familial Mediterranean Fever S Ugurlu, E Seyahi, G Hatemi, A Hacioglu, NF Akkoc, H Ozdogan Annals of the Rheumatic Diseases 73 (Suppl 2), 320-321, 2014 | 2 | 2014 |
| Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib Y Iriagac, E Cavdar, K Karaboyun, SY Tacar, FNA Mustafayev, E Celik, ... Journal of cancer research and therapeutics 19 (2), 376-381, 2023 | 1 | 2023 |
| Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study M Hizal, B Bilgin, N Paksoy, S Kılıçkap, MM Atcı, S Kahraman, ... Future Oncology 18 (23), 2573-2582, 2022 | 1 | 2022 |
| Evaluation of biomarkers of response in patients with breast cancer with BRCA 1/2 pathogenic variants treated with PARP inhibitors. FN Akkoc Mustafayev, AM Gutierrez, MF Munsell, J Chen, K Schlacher, ... Journal of Clinical Oncology 42 (16_suppl), e15188-e15188, 2024 | | 2024 |
| Abstract PO5-09-04: Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants FA Mustafayev, AG Barrera, D Liu, B Arun Cancer Research 84 (9_Supplement), PO5-09-04-PO5-09-04, 2024 | | 2024 |
| Abstract PO4-06-06: Clinical Implications of Body Mass Index (BMI) in BRCA-associated Advanced Breast Cancer Patients Treated With PARP (Poly ADP-Ribose Polymerase) Inhibitors FA Mustafayev, M Munsell, R Layman, C Yam, AG Barrera, B Arun Cancer Research 84 (9_Supplement), PO4-06-06-PO4-06-06, 2024 | | 2024 |
| Atorvastatin modulates serum biomarkers in women at increased risk for breast cancer AL Lanier, J Fahrmann, FN Mustafayev, A Gutierrez Barrera, PH Brown, ... Cancer Research 84 (6_Supplement), 778-778, 2024 | | 2024 |
| Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor–Negative Breast Cancer Chemoprevention FNA Mustafayev, DD Liu, AM Gutierrez, JE Lewis, NK Ibrahim, V Valero, ... European Journal of Breast Health 19 (4), 267, 2023 | | 2023 |
| Characteristics and clinical outcome of BRCA germline mutation carriers with advanced breast cancer treated with PARP (poly ADP-ribose polymerase) inhibitors: A single … FN Akkoc Mustafayev, M Munsell, AM Gutierrez-Barrera, C Yam, ... Journal of Clinical Oncology 41 (16_suppl), 10587-10587, 2023 | | 2023 |
| The percentage of ALK-positive cells and the efficacy of first-line M Hizal, B Bilgin, N Paksoy, MM Atci, S Kahraman, S Kilickap, DC Guven, ... | | 2023 |
| Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations FN Akkoc Mustafayev, MA Shukla, A Lanier, DR Milton, AM Gutierrez, ... Cancer, 2023 | | 2023 |
| TREATMENT OF ACUTE HEPATITIS A K MUSTAFAYEV, FNA MUSTAFAYEV, R OZARAS A Clinical Guide to the Treatment of Viral Hepatitis, 1, 2022 | | 2022 |
| Advances in the Systemic Treatment of Non-Metastatic Breast Cancer FNA MUSTAFAYEV, B ARUN Turkiye Klinikleri General Surgery-Special Topics 15 (4), 55-62, 2022 | | 2022 |
GULEN HATEMIİstanbul Üniversitesi - CerrahpaşaVerified email at iuc.edu.tr
